Пятый элемент здоровья. Как использовать менструальный цикл для поддержания жизненно важных функций организма - Лиза Хендриксон-Джек

composition of the eggs of caged hens and pastured hens.” Renewable Agriculture and Food Systems 25, no. 1 (2010): 45–54.

64. Ratliff, Joseph, Jose O. Leite, Ryan de Ogburn, Michael J. Puglisi, Jaci VanHeest, and Maria Luz Fernandez. “Consuming eggs for breakfast influences plasma glucose and ghrelin, while reducing energy intake during the next 24 hours in adult men.” Nutrition Research 30, no. 2 (2010): 96–103.

65. Swanson, Danielle, Robert Block, and Shaker A. Mousa. “Omega-3 fatty acids EPA and DHA: health benefits throughout life.” Advances in Nutrition 3, no. 1 (2012): 1–7.

66. Innis, Sheila M. “Dietary (n-3) fatty acids and brain development.” The Journal of Nutrition 137, no. 4 (2007): 855–859; Calder, Philip C. “Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance.” Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids 1851, no. 4 (2015): 469–484.

67. Goyens, Petra L.L., Mary E. Spilker, Peter L. Zock, Martijn B. Katan, and Ronald P. Mensink. “Compartmental modeling to quantify α-linolenic acid conversion after longer term intake of multiple tracer boluses.” Journal of Lipid Research 46, no. 7 (2005): 1474–1483.

68. Hussein, Nahed, Eric Ah-Sing, Paul Wilkinson, Clare Leach, Bruce A. Griffin, and D. Joe Millward. “Long-chain conversion of [13C] linoleic acid and α-linolenic acid in response to marked changes in their dietary intake in men.” Journal of Lipid Research 46, no. 2 (2005): 269–280.

69. Doughman, Scott D., Srirama Krupanidhi, and Carani B. Sanjeevi. “Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA.” Current Diabetes Reviews 3, no. 3 (2007): 198–203.

70. Nehra, Deepika, Hau D. Le, Erica M. Fallon, Sarah J. Carlson, Dori Woods, Yvonne A. White, Amy H. Pan et al. “Prolonging the female reproductive lifespan and improving egg quality with dietary omega-3 fatty acids.” Aging Cell 11, no. 6 (2012): 1046–1054.

71. Al-Safi, Zain A., Huayu Liu, Nichole E. Carlson, Justin Chosich, Mary Harris, Andrew P. Bradford, Celeste Robledo, Robert H. Eckel, and Alex J. Polotsky. “Omega-3 fatty acid supplementation lowers serum FSH in normal weight but not obese women.” The Journal of Clinical Endocrinology & Metabolism 101, no. 1 (2016): 324–333.

72. Karsch, Fred J., Deborah F. Battaglia, Kellie M. Breen, Nathalie Debus, and Thomas G. Harris. “Mechanisms for ovarian cycle disruption by immune/inflammatory stress.” Stress 5, no. 2 (2002): 101–112.

73. Price, Weston A. (2016). Nutrition and Physical Degeneration, 8th edition. Lemon Grove, CA: Price-Pottenger Nutrition Foundation, 366.

74. Tian, X., and F.J. Diaz. “Zinc depletion causes multiple defects in ovarian function during the periovulatory period in mice.” Endocrinology 153, no. 2 (2012): 873–886.

75. Hunt, Janet R. “Bioavailability of iron, zinc, and other trace minerals from vegetarian diets.” The American Journal of Clinical Nutrition 78, no. 3 (2003): 633S–639S.

76. Harland, Barbara F., and Donald Oberleas. “Phytate in foods.” World Review of Nutrition and Dietetics 52 (1987): 235–259; Hunt, Janet R. “Bioavailability of iron, zinc, and other trace minerals from vegetarian diets.” The American Journal of Clinical Nutrition 78, no. 3 (2003): 633S–639S.

77. Eskin, Bernard A., Carolyn E. Grotkowski, Christopher P. Connolly, and William R. Ghent. “Different tissue responses for iodine and iodide in rat thyroid and mammary glands.” Biological Trace Element Research 49, no. 1 (1995): 9–19; Eskin, Bernard A., Doris G. Bartuska, Marvin R. Dunn, Ginette Jacob, and Mary B. Dratman. “Mammary Gland Dysplasia in Iodine Deficiency: Studies in Rats.” JAMA 200, no. 8 (1967): 691–695; Eskin, Bernard A., Richard Shuman, Theodore Krouse, and Judith A. Merion. “Rat mammary gland atypia produced by iodine blockade with perchlorate.” Cancer Research 35, no. 9 (1975): 2332–2339.

78. Ghent, W.R., Bernard A. Eskin, D.A. Low, and L.P. Hill. “Iodine replacement in fibrocystic disease of the breast.” Canadian Journal of Surgery 36, no 5. (1993): 453–60.

79. Aceves, Carmen, Brenda Anguiano, and Guadalupe Delgado. “Is iodine a gatekeeper of the integrity of the mammary gland?” Journal of Mammary Gland Biology and Neoplasia 10, no. 2 (2005): 189–196.

80. Sarkar, A.K. “Therapeutic management of anoestrus cows with diluted Logul’s iodine and massage on reproductive organs – uncontrolled case study.” Research Journal of Animal and Veterinary Sciences 1, no. 1 (2006): 30–32; Gupta, Raman, M.S. Thakur, and Arvind Sharma. “Estrus induction and fertility response in true anestrus buffaloes using lugol’s iodine.” Animal Reproduction 20, no. 1 (2011): 12–14; Ahlawat, A.R., P.U. Gajbhiye, M.D. Odedra, V.B. Dongre, and S.N. Ghodasara. “Effect of Lugol’s iodine on estrus induction and fertility response in true anestrus Jaffrabadi buffaloes.” Buffalo Bulletin 35, no. 3 (2016): 303–305.

81. Sarkar, A.K. “Therapeutic management of anoestrus cows with diluted Logul’s iodine and aassage on reproductive organs – uncontrolled case study.” Research Journal of Animal and Veterinary Sciences 1, no. 1 (2006): 30–32.

82. Там же.

83. Brownstein, David. (2008). Iodine: Why You Need It, Why You Can’t Live Without It. Arden, NC: Medical Alternatives Press.

84. Scaldaferri, Franco, Marco Pizzoferrato, Viviana Gerardi, Loris Lopetuso, and Antonio Gasbarrini. “The gut barrier: new acquisitions and therapeutic approaches.” Journal of Clinical Gastroenterology 46 (2012): S12–S17.

85. Lopetuso, Loris Riccardo, Franco Scaldaferri, G. Bruno, V. Petito, F. Franceschi, and A. Gasbarrini. “The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.” European Review for Medical and Pharmacological Sciences 19, no. 6 (2015): 1068–1076.

86. Bischoff, Stephan C., Giovanni Barbara, Wim Buurman, Theo Ockhuizen, Jörg-Dieter Schulzke, Matteo Serino, Herbert Tilg, Alastair Watson, and Jerry M. Wells. “Intestinal permeability – a new target for disease prevention and therapy.” BMC Gastroenterology 14, no. 1 (2014): 189.

87. Chang, Jeff, Rupert W. Leong, Valerie C. Wasinger, Matthew Ip, Michael Yang, and Tri Giang Phan. “Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing.” Gastroenterology 153, no. 3 (2017): 723–731.

88. Odenwald, Matthew A., and Jerrold R. Turner. “Intestinal permeability defects: is it time to treat?” Clinical Gastroenterology and Hepatology 11, no. 9 (2013): 1075–1083.

89. Scaldaferri, Franco, Loris Riccardo Lopetuso, Valentina Petito, Valerio Cufino, Mirna Bilotta, Vincenzo Arena, Egidio Stigliano et al. “Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD?” United European Gastroenterology Journal 2, no. 2 (2014): 113–122.

90. Li,